Kelly Lim

ORCID: 0000-0003-4606-7588
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myeloid Leukemia Research
  • Granular flow and fluidized beds
  • Cytokine Signaling Pathways and Interactions
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Fluid Dynamics and Mixing
  • Cyclone Separators and Fluid Dynamics
  • Hematopoietic Stem Cell Transplantation
  • Cancer, Hypoxia, and Metabolism
  • Immune cells in cancer
  • Chronic Myeloid Leukemia Treatments
  • Epigenetics and DNA Methylation
  • Particle Dynamics in Fluid Flows
  • Minerals Flotation and Separation Techniques
  • Chronic Lymphocytic Leukemia Research
  • Metabolomics and Mass Spectrometry Studies
  • Cancer Genomics and Diagnostics
  • Mineral Processing and Grinding
  • Histone Deacetylase Inhibitors Research
  • Fluid Dynamics and Heat Transfer
  • Cancer, Lipids, and Metabolism
  • Eosinophilic Disorders and Syndromes
  • Fluid Dynamics and Turbulent Flows
  • Silk-based biomaterials and applications
  • Retinoids in leukemia and cellular processes
  • Amino Acid Enzymes and Metabolism

The University of Adelaide
1990-2025

South Australian Health and Medical Research Institute
2021-2025

Tan Tock Seng Hospital
2025

Kaohsiung Medical University
2017-2024

Kaohsiung Medical University Chung-Ho Memorial Hospital
2017-2024

UNSW Sydney
1988-2006

National University of Singapore
2004

University of British Columbia
1995-1999

10.1016/0301-9322(95)00038-y article EN International Journal of Multiphase Flow 1995-12-01

Abstract Isocitrate dehydrogenase 1 and 2 (IDH) are mutated in multiple cancers drive production of (R)-2-hydroxyglutarate (2HG). We identified a lipid synthesis enzyme [acetyl CoA carboxylase (ACC1)] as synthetic lethal target mutant IDH1 (mIDH1), but not mIDH2, cancers. Here, we analyzed the metabolome primary acute myeloid leukemia (AML) blasts an mIDH1-specific reduction fatty acids. mIDH1 also induced switch to b-oxidation indicating reprogramming metabolism toward reliance on Compared...

10.1158/2159-8290.cd-21-0218 article EN cc-by-nc-nd Cancer Discovery 2022-11-10

Report14 February 2022Open Access Source DataTransparent process Targeting human CALR-mutated MPN progenitors with a neoepitope-directed monoclonal antibody Denis Tvorogov orcid.org/0000-0002-2009-1347 Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia Contribution: Conceptualization, Formal analysis, Supervision, Funding acquisition, Validation, ​Investigation, Visualization, Methodology, Writing - original draft, review & editing Search more...

10.15252/embr.202152904 article EN cc-by EMBO Reports 2022-02-14

Abstract Rare preleukemic hematopoietic stem cells (pHSC) harboring only the initiating mutations can be detected at time of acute myeloid leukemia (AML) diagnosis. pHSCs are origin and a potential reservoir for relapse. Using primary human samples gene editing to model isocitrate dehydrogenase 1 (IDH1) mutant pHSCs, we show epigenetic, transcriptional, metabolic differences between healthy (HSC). We confirm that IDH1-driven clonal hematopoiesis is associated with cytopenia, suggesting an...

10.1158/2643-3230.bcd-23-0195 article EN Blood Cancer Discovery 2023-12-12

Abstract The interaction of germline variation and somatic cancer driver mutations is under-investigated. Here we describe the genomic mitochondrial landscape in adult acute myeloid leukaemia (AML) show that rare variants affecting nuclear- mitochondrially-encoded complex I genes near-mutual exclusivity with isocitrate dehydrogenase 1 ( IDH1 ), but not IDH2 suggesting a unique epistatic relationship. Whereas AML cells or all display attenuated respiration, heightened sensitivity to...

10.1038/s41467-022-30223-9 article EN cc-by Nature Communications 2022-05-12

Therapy-related myeloid neoplasm (tMN) is considered a direct consequence of DNA damage in hematopoietic stem cells. Despite increasing recognition that altered stroma can also drive leukemogenesis, the functional biology tMN microenvironment remains unknown. We performed multiomic (transcriptome, response, cytokine secretome and profiling) characterization bone marrow stromal cells from patients. Critically, we compared (i) patients with another cancer but without cytotoxic exposure, (ii)...

10.1038/s41375-022-01686-y article EN cc-by Leukemia 2022-08-29

High prevalence of IDH mutations in seronegative rheumatoid arthritis (RA) with myeloid neoplasm, elevated 2-hydroxyglutarate, dysregulated innate immunity, and proinflammatory microenvironment suggests causative association between RA. Our findings merit investigation inhibitors as therapeutics for IDH-mutated

10.1182/blood.2023023593 article EN cc-by-nc-nd Blood 2024-03-08

Age-related macular degeneration (AMD) is associated with chronic inflammation of the retinal pigment epithelium (RPE) and elevated cytokines including TNFα, TGF-β, IL-6, IL-1β. As a metabolic intermediary supporting aerobic glycolysis in adjacent photoreceptors, RPE's responses to optimal methods study cytokine-driven programming remain unclear. We performed rigorous comparison ARPE-19 cells rat eyecup metabolomes, revealing key distinctions. Rat eyecups exhibit higher levels lactate...

10.1038/s41598-025-93882-w article EN cc-by-nc-nd Scientific Reports 2025-04-15

A nurse new to home peritoneal dialysis (PD) undoubtedly has learn all the steps for continuous ambulatory (CAPD) and automated (APD) procedures, along with basics such as hand hygiene, ordering supplies, disposing of recognizing signs symptoms peritonitis. However, it is not always clear what else PD needs know in order successfully teach a patient that (and care partner) starting training need know, well support overtime once performing at home. To answer this question, using modified...

10.1177/08968608251331832 article EN Peritoneal Dialysis International 2025-04-15

<p>Supplementary Figure 1. IDH2 is mutated in preleukemic hematopoietic stem cells relapse causing clones AML. Supplementary 2. Single-cell RNA sequencing and combined genotyping reveal distinct transcriptomic profiles of IDH1-mutant pHSCs AML 3. Modeling human using CRISPR/Cas9 with HDR show reduced proliferation blocked differentiation caused by IDH1 mutations 4. reduce 5-hydroxymethylcytosine gene bodies 5. drives alterations 6. are sensitive to inhibition oxidative phosphorylation</p>

10.1158/2643-3230.25324081.v1 preprint EN cc-by 2024-03-01

Abstract Lateral and axial profiles of solids cross‐flow flux were measured in a circulating fluidized bed riser square cross‐section with sampling probe. The was found to be higher near the wall, especially corners, lower core riser. net horizontal outwards part inwards top. lateral momentum flux, by means piezoelectric probe, increased height then decreased top first distance from axis towards wall. It low corners.

10.1002/cjce.5450730504 article EN The Canadian Journal of Chemical Engineering 1995-10-01

<div>Abstract<p>Rare preleukemic hematopoietic stem cells (pHSC) harboring only the initiating mutations can be detected at time of acute myeloid leukemia (AML) diagnosis. pHSCs are origin and a potential reservoir for relapse. Using primary human samples gene editing to model <i>isocitrate dehydrogenase 1</i> (<i>IDH1</i>) mutant pHSCs, we show epigenetic, transcriptional, metabolic differences between healthy (HSC). We confirm that...

10.1158/2643-3230.c.7099981.v1 preprint EN 2024-03-01
Coming Soon ...